"Emory's strong basic and translational science programs within the Emory Vaccine Center and our infectious
diseases programs in the Emory Children's Center, combined with our track record in clinical trials and infectious
diseases treatment and research in adults and children, presented a very strong portfolio to the NIH," says
Mark Mulligan, MD, principal investigator of the Emory VTEU, professor of medicine in Emory University
School of Medicine and executive director of the Hope Clinic of the Emory Vaccine Center.
"We are excited to have this opportunity to make a major contribution to our nation's vaccine development efforts," says
Harry Keyserling, MD, Emory professor of pediatrics and a co-director of the Emory VTEU. "Vaccines have always been our
most effective weapons in battling diseases that broadly affect public health. We also look forward to working with our
superb collaborators at CDC, KaiserPermanente Georgia, Mayo Clinic, and the University of Colorado."
To improve the lives of individuals globally through research into vaccines and preventive measures against
infectious diseases.
To do this, we have recruited an outstanding group of clinical vaccinologists who work closely with
government, industry, and academic leaders in the design and performance of clinical trials. Investigators
within the Emory VTEU are engaged in understanding fundamental aspects of human immunologic responses to
vaccines. The investigators, staff, and volunteers of the Emory VTEU are poised to make major contributions
to the development of improved vaccines and preventive measures against infectious diseases.
